drugdeliverybusiness2d
Embecta discontinues insulin patch pump program, plans restructuring
Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.
drugdeliverybusiness8d
Insulet Omnipod 5 is now compatible with Abbott FreeStyle Libre 2 Plus in the U.S.
Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...
drugdeliverybusiness9d
Dexcom invests $75M in Oura as companies strike health monitoring partnership
Dexcom announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology.
drugdeliverybusiness8d
Medtronic wins FDA nod for new InPen app to support launch with Simplera CGM
Medtronic announced today that it received FDA clearance for its new InPen insulin delivery system application.
drugdeliverybusiness8d
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.
drugdeliverybusiness9d
Medtronic to submit MiniMed 780G to FDA for type 2 diabetes in 2025, updates on patch pump
Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.
drugdeliverybusiness8d
Food & Drug Administration (FDA)
R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its Magnitude drug-eluting bioresorbable scaffold. Mountain View, California-based R3 Vascular ...